Cargando…
Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people
BACKGROUND: Representativeness of antihypertensive drug trials is uncertain, as many trials recruit few or no older people. Some trials specifically recruit older participants to address this. Here, we assess the representativeness of trials focusing on older people by comparing the rates of serious...
Autores principales: | Hanlon, Peter, Corcoran, Neave, Rughani, Guy, Shah, Anoop S V, Mair, Frances S, Guthrie, Bruce, Renton, Joanne P, McAllister, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245327/ https://www.ncbi.nlm.nih.gov/pubmed/34240062 http://dx.doi.org/10.1016/S2666-7568(21)00092-1 |
Ejemplares similares
-
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022) -
The readability of general practice websites: a cross-sectional analysis of all general practice websites in Scotland
por: Rughani, Guy, et al.
Publicado: (2021) -
Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
por: Wightman, Heather, et al.
Publicado: (2023) -
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis
por: Hanlon, Peter, et al.
Publicado: (2020) -
Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)